Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies
Radu Constantinescu(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital), Lars Rosengren(Sahlgrenska University Hospital), Clas Malmeström(University of Gothenburg), Ubah Mahamud(Sahlgrenska University Hospital), Filip Bergquist(Sahlgrenska University Hospital), Markus Axelsson(Sahlgrenska University Hospital), Daniel Jons(Sahlgrenska University Hospital), Ulf Andréasson(Sahlgrenska University Hospital), Kerstin Andrén(Sahlgrenska University Hospital), Henrik Zetterberg(National Hospital for Neurology and Neurosurgery), Fredrik Asztély(University of Gothenburg), Elinor Ben Menachem(Sahlgrenska University Hospital), David Krýsl(Sahlgrenska University Hospital)
Cited by 22
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k